18 May – 21 May 2019 in MELBOURNE CONVENTION AND EXHIBITION CENTRE, MELBOURNE, VICTORIA, AUSTRALIA
Shiitake dermatitis after ‘detoxification’ diet
Isobornyl acrylate and the rising incidence of contact dermatitis to glucose sensors
Systemic treatment for vitiligo: Why, when and how?
Durability of response in plaque psoriasis patients receiving certolizumab pegol over 48 Weeks in phase 3 studies: CIMPASI-1, CIMPASI-2, CIMPACT
Efficacy of certolizumab pegol in psoriasis patients failing to respond to etanercept in an ongoing, phase 3, randomised controlled study
5 Adult cases of granular parakeratosis associated with enzalkonium chloride exposure through laundry rinse aid
Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma in an Australian Cohort.
Lichen aureus: A case report and histopathological presentation of a rare subtype of pigmented purpuric dermatoses
Mycosis fungoides masquerading as a pigmented purpuric dermatosis
Which came first, purpuric mycosis fungoides or pigmented purpuric dermatosis? A diagnostic dilemma
Allergic contact dermatitis to alcohol swabs masquerading as a tape allergy
An unusual reaction following allergic contactdermatitis to grevillea Robyn Gordon
A case series of 13 patients with oestrogen hypersensitivity vulvitis treated with cyproterone acetate
Case report: repigmentation of vitiligo with oral baricitinib
A non-interventional-prospective-12-month study to characterise REAL-life effectiveness and treatmentpatterns of secukinumab, and current standard-of-care of chronic plaque psoriasis in Asia-Pacific & MiddleEast
Steroid-sparing agents for alopecia areata: a retrospective review of 150 patients
Dermatology in Madagascar – The role for a future telecommunication service
2021 Dermcoll, 53RD ANNUAL SCIENTIFIC MEETING, THE ART OF DERMATOLOGY
2019 Dermcoll, 52ND ANNUAL SCIENTIFIC MEETING
